Psoriatic arthritis patients find condition difficult to diagnose and often misunderstood

November 16, 2016

Philadelphia, November 16, 2016 - Psoriatic Arthritis In America 2016, is a new national survey by Health Union of over 500 individuals suffering from psoriatic arthritis (PsA). The results reveal that the diagnosis process is often frustrating and lengthy, and that most patients experience multiple symptoms before leading to a diagnosis. In addition, respondents reported difficulty explaining often invisible symptoms that progress and become more debilitating over time.

Psoriatic arthritis (PsA) is an inflammatory condition closely related to and most often co-occurring with psoriasis. Both are chronic life-long autoimmune conditions. While psoriasis affects the skin, causing red, scaly patches that are often painful and itchy; PsA has highly variable symptoms that present in different patterns with different patients. Some of the most common symptoms are pain, swelling, and stiffness of the joints; inflammation and pain of ligaments and tendons at attachment points; and fatigue.

In the majority of cases psoriasis precedes psoriatic arthritis, with PsA often developing within five to ten years after the onset of psoriasis. However, in about 10 to 15 percent of patients, PsA will develop before psoriasis. Almost two-thirds of survey respondents were also diagnosed with psoriasis, with 71% of these diagnosed with psoriasis first. Forty-four percent of respondents went more than 10 years between diagnoses.

Psoriatic arthritis is often undiagnosed or misdiagnosed. There is no definitive test for PsA, instead patients are evaluated most often with Classification Criteria for Psoriatic Arthritis (or CASPAR). On average, survey respondents went 6.6 years from symptom onset prior to diagnosis and underwent an average of 4.9 diagnostic tests. Forty-one percent visited four or more healthcare professionals. This difficulty in diagnosis is made even more problematic because early diagnosis is critical. Treatment not only helps manage painful symptoms, but also can slow the potentially disfiguring progression of the disease.

The story of Diane Talbert, a community advocate, is representative of the diagnostic difficulty. "I have had psoriasis for 50 years and psoriatic arthritis for 25. The problem is that I have always seen a doctor over this time, but nobody ever put two and two together that I had psoriatic arthritis. It was extremely hard to get a diagnosis. The doctors knew my medical history and did plenty of blood tests over the years. I had MRI's and x-rays done. I had the symptoms of psoriatic arthritis, but it was only 10 years ago that a doctor finally said I had psoriatic arthritis. It was quite a long hard road."

On average, survey participants experienced a combination of six different symptoms that led them to being diagnosed with PsA. Some of the initial symptoms reported were joint involvement (83%), musculoskeletal lesions (76%), and nail involvement (37%), with 28% reporting all three of these symptoms.

Similar to other autoimmune diseases, there is currently no cure for PsA. In addition, over time symptoms progress and can cause permanent, irreversible joint damage. The most common symptoms are also the most difficult to manage. When asked to identify the most difficult symptoms to manage, 82% note fatigue; 80% painful, swollen, or stiff joints; and 61% lower back and/or neck pain.

"But you don't look sick - I hear this often. It's hard to explain that you go to bed in pain and wake up in pain. Having inflammation in your joints is hard to explain," said Talbert. "I take care of myself, so I look the picture of health. My symptoms have been achy joints to swelling of the fingers and toes and inflammation in the joints. Sometimes this pain can last 24 hours a day or more. Anyone living with this disease knows that you can have your good days and your bad days. Other people often don't understand."

Most PsA symptoms are largely hidden. This invisibility can lead to feelings of isolation. As well, the physical limitations and impact on their life are often misunderstood and underestimated. When survey participants were asked which aspects of PsA where most difficult to explain to others, 82% cited that PsA can cause serious fatigue, 71% that it causes different types of pain, 66% that there are other symptoms not related to joints, and 55% that PsA is different from osteoarthritis.

"The fact that so many people with PsA feel misunderstood and isolated shows the value of a site like This online community provides a place for people with similar experiences to come together for much needed support," says Tim Armand, President and co-founder of Health Union. "In addition, there is a lot of great, new research out there and serves as an invaluable outlet for the PsA community to learn from each other and find information on the latest treatments."

The Psoriatic Arthritis in America 2016 survey was conducted online between June 20 and July 27, 2016. More details about the survey are available upon request.

About Health Union, LLC and

Health Union inspires people to live better with challenging health conditions - combining new, original content every day with digital, social and mobile technologies to cultivate active online health communities. Health Union platforms are unique ecosystems dedicated to illuminating the voices and experiences of people with type two diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis C, and more. Its services and offerings foster open and honest interactions about these health conditions between and among patients, caregivers, professionals, providers and industry partners to help all stakeholders make more informed decisions about healthcare. is Health Union's online community dedicated to people living with psoriatic arthritis, where patients and supporters of people living with this condition can connect, share experiences and learn about managing the condition.

Health Union

Related Arthritis Articles from Brightsurf:

Physical activity and sleep in adults with arthritis
A new study published in Arthritis Care & Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

The ACR and the Arthritis Foundation present new guidelines offering therapeutic approaches and treatment options for juvenile idiopathic arthritis
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA).

Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects.

Read More: Arthritis News and Arthritis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to